Structural and Functional Analysis of a Platelet-Activating Lysophosphatidylcholine of Trypanosoma cruzi

PLoS Neglected Tropical Diseases

Volumn 8, Issue 8, 2014, Pages

  Gazos Lopes, Felipe ^a   Oliveira, Mauricio M ^b   Hoelz, Lucas V B ^b   Vieira, Danielle P ^b   Marques, Alexandre F ^a,c   Nakayasu, Ernesto S ^a,d   Gomes, Marta T ^b   Salloum, Nasim G ^a   Pascutti, Pedro G ^b   Souto Padrón, Thaïs ^b   Monteiro, Robson Q ^b   Lopes, Angela H ^b   Almeida, Igor C ^a  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPID; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; APAFANT; AZEPINE DERIVATIVE; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; TRIAZOLE DERIVATIVE;

AMASTIGOTE; AMINO ACID SEQUENCE; ARTICLE; BIOINFORMATICS; CHAGAS DISEASE; ELECTROSPRAY MASS SPECTROMETRY; EPIMASTIGOTE; EXOSOME; MOLECULAR DOCKING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SOLID PHASE EXTRACTION; THROMBOCYTE AGGREGATION; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; RABBIT; TANDEM MASS SPECTROMETRY;

ANIMALS; AZEPINES; LYSOPHOSPHATIDYLCHOLINES; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION; PLATELET MEMBRANE GLYCOPROTEINS; RABBITS; RECEPTORS, G-PROTEIN-COUPLED; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TRIAZOLES; TRYPANOSOMA CRUZI;

EID: 84952334127     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003077     Document Type: Article

References (103)

1. Machado FS, Dutra WO, Esper L, Gollob KJ, Teixeira MM, et al. (2012) Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease. Semin Immunopathol 34: 753–770.
2. Mukherjee S, Machado FS, Huang H, Oz HS, Jelicks LA, et al. (2011) Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease. PLoS One 6: e16959.
3. Ropert C, Almeida IC, Closel M, Travassos LR, Ferguson MA, et al. (2001) Requirement of mitogen-activated protein kinases and I kappa B phosphorylation for induction of proinflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial lipopolysaccharide. J Immunol 166: 3423–3431.
4. Tanowitz HB, Burns ER, Sinha AK, Kahn NN, Morris SA, et al. (1990) Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy. Am J Trop Med Hyg 43: 274–281.
5. Carod-Artal FJ, Vargas AP, Horan TA, Nunes LG, (2005) Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke; a journal of cerebral circulation 36: 965–970.
6. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR, (2008) The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2: e300.
7. Schmunis GA, Yadon ZE, (2010) Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 115: 14–21.
8. Tyler KM, Engman DM, (2001) The life cycle of Trypanosoma cruzi revisited. Int J Parasitol 31: 472–481.
9. Sanchez LV, Ramirez JD, (2013) Congenital and oral transmission of American trypanosomiasis: an overview of physiopathogenic aspects. Parasitology 140: 147–159.
10. Schmunis GA, Yadon ZE, (2010) Chagas disease: a Latin American health problem becoming a world health problem. Acta tropica 115: 14–21.
11. Aliberti JC, Machado FS, Gazzinelli RT, Teixeira MM, Silva JS, (1999) Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. Infect Immun 67: 2810–2814.
12. Ashton AW, Mukherjee S, Nagajyothi FN, Huang H, Braunstein VL, et al. (2007) Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J Exp Med 204: 929–940.
13. Freire-de-Lima CG, Nascimento DO, Soares MB, Bozza PT, Castro-Faria-Neto HC, et al. (2000) Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403: 199–203.
14. Gomes MT, Monteiro RQ, Grillo LA, Leite-Lopes F, Stroeder H, et al. (2006) Platelet-activating factor-like activity isolated from Trypanosoma cruzi. Int J Parasitol 36: 165–173.
15. Talvani A, Machado FS, Santana GC, Klein A, Barcelos L, et al. (2002) Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. Infect Immun 70: 4247–4253.
16. Talvani A, Santana G, Barcelos LS, Ishii S, Shimizu T, et al. (2003) Experimental Trypanosoma cruzi infection in platelet-activating factor receptor-deficient mice. Microbes Infect 5: 789–796.
17. Mesquita RD, Carneiro AB, Bafica A, Gazos-Lopes F, Takiya CM, et al. (2008) Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine. Infect Immun 76: 5543–5552.
18. Silva-Neto MA, Carneiro AB, Silva-Cardoso L, Atella GC, (2012) Lysophosphatidylcholine: a novel modulator of Trypanosoma cruzi transmission. J Parasitol Res 2012: 625838.
19. Golodne DM, Monteiro RQ, Graca-Souza AV, Silva-Neto MA, Atella GC, (2003) Lysophosphatidylcholine acts as an anti-hemostatic molecule in the saliva of the blood-sucking bug Rhodnius prolixus. J Biol Chem 278: 27766–27771.
20. Bassa BV, Noh JW, Ganji SH, Shin MK, Roh DD, et al. (2007) Lysophosphatidylcholine stimulates EGF receptor activation and mesangial cell proliferation: regulatory role of Src and PKC. Biochim Biophys Acta 1771: 1364–1371.
21. Kabarowski JH, (2009) G2A and LPC: regulatory functions in immunity. Prostaglandins Other Lipid Mediat 89: 73–81.
22. Oestvang J, Anthonsen MW, Johansen B, (2011) LysoPC and PAF trigger arachidonic acid release by divergent signaling mechanisms in monocytes. J Lipids 2011: 532145.
23. Legradi A, Chitu V, Szukacsov V, Fajka-Boja R, Szekely Szucs K, et al. (2004) Lysophosphatidylcholine is a regulator of tyrosine kinase activity and intracellular Ca(2+) level in Jurkat T cell line. Immunol Lett 91: 17–21.
24. Meyer zu Heringdorf D, Jakobs KH, (2007) Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys Acta 1768: 923–940.
25. Honda Z, Nakamura M, Miki I, Minami M, Watanabe T, et al. (1991) Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 349: 342–346.
26. Lin P, Ye RD, (2003) The lysophospholipid receptor G2A activates a specific combination of G proteins and promotes apoptosis. J Biol Chem 278: 14379–14386.
27. Lum H, Qiao J, Walter RJ, Huang F, Subbaiah PV, et al. (2003) Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells. Am J Physiol Heart Circ Physiol 285: H1786–1789.
28. Murugesan G, Sandhya Rani MR, Gerber CE, Mukhopadhyay C, Ransohoff RM, et al. (2003) Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines. J Mol Cell Cardiol 35: 1375–1384.
29. Pexa A, Deussen A, (2005) Modulation of ecto-5′-nucleotidase by phospholipids in human umbilical vein endothelial cells (HUVEC). Naunyn Schmiedebergs Arch Pharmacol 372: 131–138.
30. Rao SP, Riederer M, Lechleitner M, Hermansson M, Desoye G, et al. (2013) Acyl chain-dependent effect of lysophosphatidylcholine on endothelium-dependent vasorelaxation. PLoS One 8: e65155.
31. Tsuda M, Tozaki-Saitoh H, Inoue K, (2011) Platelet-activating factor and pain. Biol Pharm Bull 34: 1159–1162.
32. Zhu K, Baudhuin LM, Hong G, Williams FS, Cristina KL, et al. (2001) Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J Biol Chem 276: 41325–41335.
33. Huang YH, Schafer-Elinder L, Wu R, Claesson HE, Frostegard J, (1999) Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin Exp Immunol 116: 326–331.
34. Ojala PJ, Hirvonen TE, Hermansson M, Somerharju P, Parkkinen J, (2007) Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophils. J Leukoc Biol 82: 1501–1509.
35. Riederer M, Ojala PJ, Hrzenjak A, Graier WF, Malli R, et al. (2010) Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production. J Lipid Res 51: 2957–2966.
36. Agusti R, Couto AS, Alves MJ, Colli W, Lederkremer RM, (2000) Lipids shed into the culture medium by trypomastigotes of Trypanosoma cruzi. Mem Inst Oswaldo Cruz 95: 97–102.
37. Ramos RG, Libong D, Rakotomanga M, Gaudin K, Loiseau PM, et al. (2008) Comparison between charged aerosol detection and light scattering detection for the analysis of Leishmania membrane phospholipids. J Chromatogr A 1209: 88–94.
38. Zheng L, T'Kind R, Decuypere S, von Freyend SJ, Coombs GH, et al. (2010) Profiling of lipids in Leishmania donovani using hydrophilic interaction chromatography in combination with Fourier transform mass spectrometry. Rapid Commun Mass Spectrom 24: 2074–2082.
39. Werbovetz KA, Englund PT, (1996) Lipid metabolism in Trypanosoma brucei: utilization of myristate and myristoyllysophosphatidylcholine for myristoylation of glycosyl phosphatidylinositols. Biochem J 318(Pt 2): 575–581.
40. Asahi H, (2009) Plasmodium falciparum: Chemically defined medium for continuous intraerythrocytic growth using lipids and recombinant albumin. Exp Parasitol 121: 22–28.
41. Smith JC, Hou W, Whitehead SN, Ethier M, Bennett SA, et al. (2008) Identification of lysophosphatidylcholine (LPC) and platelet activating factor (PAF) from PC12 cells and mouse cortex using liquid chromatography/multi-stage mass spectrometry (LC/MS3). Rapid Commun Mass Spectrom 22: 3579–3587.
42. Honda Z, Ishii S, Shimizu T, (2002) Platelet-activating factor receptor. J Biochem 131: 773–779.
43. Kasperska-Zajac A, Brzoza Z, Rogala B, (2008) Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy. Recent Pat Inflamm Allergy Drug Discov 2: 72–76.
44. Silva LHP, Nussenzweig V, (1953) Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clinica et Biologica (S Paulo) 20: 191–207.
45. Camargo EP, (1964) Growth and differentiation In Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media. Rev Inst Med Trop Sao Paulo 12: 93–100.
46. de Sousa MA, (1983) A simple method to purify biologically and antigenically preserved bloodstream trypomastigotes of Trypanosoma cruzi using DEAE-cellulose columns. Mem Inst Oswaldo Cruz 78: 317–333.
47. Serrano AA, Schenkman S, Yoshida N, Mehlert A, Richardson JM, et al. (1995) The lipid structure of the glycosylphosphatidylinositol-anchored mucin-like sialic acid acceptors of Trypanosoma cruzi changes during parasite differentiation from epimastigotes to infective metacyclic trypomastigote forms. J Biol Chem 270: 27244–27253.
48. Andrews NW, Colli W, (1982) Adhesion and interiorization of Trypanosoma cruzi in mammalian cells. J Protozool 29: 264–269.
49. Marques AF, Nakayasu ES, Almeida IC, (2011) Purification of extracellular and intracellular amastigotes of Trypanosoma cruzi from mammalian host-infected cells. Protocol Exchange http://www.nature.com/protocolexchange/protocols/2240.
50. Black L, Berenbaum MC, (1964) Factors affecting the dye exclusion test for cell viability. Exp Cell Res 35: 9–13.
51. Folch J, Lees M, Sloane Stanley GH, (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497–509.
52. Pernet F, Pelletier CJ, Milley J, (2006) Comparison of three solid-phase extraction methods for fatty acid analysis of lipid fractions in tissues of marine bivalves. J Chromatogr A 1137: 127–137.
53. Whitney D, McCoy M, Gordon N, Afeyan N, (1998) Characterization of large-pore polymeric supports for use in perfusion biochromatography. J Chromatogr A 807: 165–184.
54. Hsu FF, Turk J, Thukkani AK, Messner MC, Wildsmith KR, et al. (2003) Characterization of alkylacyl, alk-1-enylacyl and lyso subclasses of glycerophosphocholine by tandem quadrupole mass spectrometry with electrospray ionization. J Mass Spectrom 38: 752–763.
55. Silva-Cardoso L, Caccin P, Magnabosco A, Patron M, Targino M, et al. (2010) Paralytic activity of lysophosphatidylcholine from saliva of the waterbug Belostoma anurum. J Exp Biol 213: 3305–3310.
56. Hsu FF, Turk J, Williams TD, Welti R, (2007) Electrospray ionization multiple stage quadrupole ion-trap and tandem quadrupole mass spectrometric studies on phosphatidylglycerol from Arabidopsis leaves. J Am Soc Mass Spectrom 18: 783–790.
57. Bayer-Santos E, Aguilar-Bonavides C, Rodrigues SP, Cordero EM, Marques AF, et al. (2013) Proteomic analysis of Trypanosoma cruzi secretome: characterization of two populations of extracellular vesicles and soluble proteins. J Proteome Res 12: 883–897.
58. Monteiro RQ, Carlini CR, Guimaraes JA, Bon C, Zingali RB, (1997) Distinct bothrojaracin isoforms produced by individual jararaca (Bothrops jararaca) snakes. Toxicon 35: 649–657.
59. Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, et al. (2003) ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 31: 3784–3788.
60. Roy A, Kucukural A, Zhang Y, (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5: 725–738.
61. Zhang Y, (2009) I-TASSER: fully automated protein structure prediction in CASP8. Proteins 77 Suppl 9: 100–113.
62. Zhang Y, (2007) Template-based modeling and free modeling by I-TASSER in CASP7. Proteins 69 Suppl 8: 108–117.
63. Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, et al. (2000) Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29: 291–325.
64. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, et al. (2007) Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci Chapter 2: Unit 2.9.
65. Laskowski R, Macarthur M, Moss D, Thornton J, (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Applied Crystallography 26: 283–291.
66. Colovos C, Yeates TO, (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 2: 1511–1519.
67. Ray A, Lindahl E, Wallner B, (2010) Model quality assessment for membrane proteins. Bioinformatics 26: 3067–3074.
68. Thomsen R, Christensen MH, (2006) MolDock: a new technique for high-accuracy molecular docking. J Med Chem 49: 3315–3321.
69. Hsu FF, Turk J, (2010) Electrospray ionization multiple-stage linear ion-trap mass spectrometry for structural elucidation of triacylglycerols: assignment of fatty acyl groups on the glycerol backbone and location of double bonds. J Am Soc Mass Spectrom 21: 657–669.
70. Belaunzaran ML, Lammel EM, de Isola EL, (2011) Phospholipases A in trypanosomatids. Enzyme Res 2011: 392082.
71. Gao Q, Wang Z, (2006) Classification of G-protein coupled receptors at four levels. Prot Engin Des Selec 19: 511–516.
72. Kobilka BK, (2007) G protein coupled receptor structure and activation. Biochim Biophys Acta 1768: 794–807.
73. Hoelz LVB, Bernardi RC, Horta BAC, Araujo JQ, Albuquerque MG, et al. (2011) Dynamical behaviour of the human beta(1)-adrenoceptor under agonist binding. Mol Simul 37: 907–913.
74. Hoelz LVB, Ribeiro AAST, Bernardi RC, Horta BAC, Albuquerque MG, et al. (2012) The role of helices 5 and 6 on the human beta(1)-adrenoceptor activation mechanism. Mol Simul 38: 236–240.
75. Ishii I, Izumi T, Tsukamoto H, Umeyama H, Ui M, et al. (1997) Alanine exchanges of polar amino acids in the transmembrane domains of a platelet-activating factor receptor generate both constitutively active and inactive mutants. J Biol Chem 272: 7846–7854.
76. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB, (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63: 1256–1272.
77. Heim AJ, Li Z, (2012) Developing a high-quality scoring function for membrane protein structures based on specific inter-residue interactions. J Comput Aided Mol Des 26: 301–309.
78. Gutierrez-de-Teran H, Bello X, Rodriguez D, (2013) Characterization of the dynamic events of GPCRs by automated computational simulations. Biochem Soc Trans 41: 205–212.
79. Belaunzaran ML, Wainszelbaum MJ, Lammel EM, Gimenez G, Aloise MM, et al. (2007) Phospholipase A1 from Trypanosoma cruzi infective stages generates lipid messengers that activate host cell protein kinase c. Parasitology 134: 491–502.
80. Belaunzaran ML, Wilkowsky SE, Lammel EM, Gimenez G, Bott E, et al. (2013) Phospholipase A1: a novel virulence factor in Trypanosoma cruzi. Mol Biochem Parasitol 187: 77–86.
81. Richmond GS, Smith TK, (2007) A novel phospholipase from Trypanosoma brucei. Mol Microbiol 63: 1078–1095.
82. Lujan HD, Bronia DH, (1994) Intermembrane lipid transfer during Trypanosoma cruzi-induced erythrocyte membrane destabilization. Parasitology 108(Pt 3): 323–334.
83. Kabbani SS, Watkins MW, Ashikaga T, Terrien EF, Holoch PA, et al. (2001) Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention. Circulation 104: 181–186.
84. Tanowitz HB, Kirchhoff LV, Simon D, Morris SA, Weiss LM, et al. (1992) Chagas' disease. Clin Microbiol Rev 5: 400–419.
85. Chao W, Olson MS, (1993) Platelet-activating factor: receptors and signal transduction. Biochem J 292: 617–629.
86. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, et al. (2006) Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics Chapter 5: Unit 5.6.
87. Lopes AH, Gomes MT, Dutra FL, Vermelho AB, Meyer-Fernandes JR, et al. (2010) Intracellular signaling pathways involved in cell differentiation in trypanosomatids. Open Parasitol J 4: 102–110.
88. Silva-Neto MA, Carneiro AB, Vieira DP, Mesquita RD, Lopes AH, (2002) Platelet-activating factor (PAF) activates casein kinase 2 in the protozoan parasite Herpetomonas muscarum muscarum. Biochem Biophys Res Commun 293: 1358–1363.
89. Ogita T, Tanaka Y, Nakaoka T, Matsuoka R, Kira Y, et al. (1997) Lysophosphatidylcholine transduces Ca2+ signaling via the platelet-activating factor receptor in macrophages. Am J Physiol 272: H17–24.
90. Huang YH, Schäfer-Elinder L, Wu R, Claesson HE, Frostegard J, (1999) Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin Exp Immunol 116: 326–331.
91. Seibt BF, Schiedel AC, Thimm D, Hinz S, Sherbiny FF, et al. (2013) The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors. Biochem Pharmacol 85: 1317–1329.
92. Buwitt-Beckmann U, Heine H, Wiesmüller K, Jung G, Brock R, et al. (2005) Lipopeptide structure determines TLR2 dependent cell activation level. FEBS J 272: 6354–6364.
93. Abdulkhalek S, Guo M, Amith SR, Jayanth P, Szewczuk MR, (2012) G-protein coupled receptor agonists mediate Neu1 sialidase and matrix metalloproteinase-9 cross-talk to induce transactivation of Toll-like receptors and cellular signaling. Cell Signal 24: 2035–2042.
94. Magalhães K, Almeida PE, Atella G, Maya-Monteiro CM, Castro-Faria-Neto HC, et al. (2010) Schistosomal-derived lysophosphatidylcholine are involved in eosinophil activation and recruitment through Toll-like receptor-2-dependent mechanisms. J Infect Dis 202: 1369–1379.
95. Carneiro AB, Iaciura BMF, Nohara LL, Lopes CD, Cordero Veas EM, et al. (2013) Lysophosphatidylcholine triggers TLR2- and TLR4-mediated signaling pathways but counteracts LPS-induced NO synthesis in peritoneal macrophages by inhibiting NF-κB translocation and MAPK/ERK phosphorylation. PLoS One 8: e76233.
96. Testet E, Laroche-Traineau J, Noubhani A, Coulon D, Bunoust O, et al. (2005) Ypr140wp, ‘the yeast tafazzin’, displays a mitochondrial lysophosphatidylcholine (lyso-PC) acyltransferase activity related to triacylglycerol and mitochondrial lipid synthesis. Biochem J 387: 617–626.
97. Richmond GS, Gibellini F, Young SA, Major L, Denton H, et al. (2010) Lipidomic analysis of bloodstream and procyclic form Trypanosoma brucei. Parasitology 137: 1357–1392.
98. Eyster KM, (2007) The membrane and lipids as integral participants in signal transduction: lipid signal transduction for the non-lipid biochemist. Adv Physiol Educ 31: 5–16.
99. Murohara T, Ikeda H, Katoh A, Takajo Y, Otsuka Y, et al. (2002) Vitamin E inhibits lysophosphatidylcholine-induced endothelial dysfunction and platelet activation. Antioxid Redox Signal 4: 791–798.
100. Ogletree ML, (1987) Overview of physiological and pathophysiological effects of thromboxane A2. FASEB J 46: 133–138.
101. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM, (2000) Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69: 419–445.
102. Zimmermann LT, Folly E, Gomes MT, Alviano DS, Alviano CS, et al. (2011) Effects of platelet-activating factor on the interaction of Trypanosoma cruzi with Rhodnius prolixus. Parasitol Res 108: 1473–1478.
103. Pereira-Chioccola VL, Acosta-Serrano A, Correia de Almeida I, Ferguson MA, Souto-Padron T, et al. (2000) Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies. J Cell Sci 113(Pt 7): 1299–1307.